Abstract
Acquired aplastic anemia (AA) is defined as a syndrome in which pancytopenia is accompanied by marrow hypocellularity. The severity of AA, in terms of the 1979 International Aplastic Anemia Study Group guidelines [1], has prognostic significance. An extremely useful recent addition to these criteria is the definition of very severe aplastic anemia (VSAA) by the European Bone Marrow Transplant Group's Severe Aplastic Anemia Working Party [2]. While the prognosis in patients with AA has been improved with refinement of bone marrow transplantation [2] and immunosuppression [3], patients with VSAA, particularly when combined with infection, still have a poor prognosis. The availability of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) has enabled the start of numerous trails to investigate the therapeutic value of rhGM-CSF in AA [4–11]. The majority of patients included in these trials did not fulfill the criteria of VSAA, i.e., they had significant residual myelopoiesis. With one exception [5] they were free of infections when entering the study.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Camitta BM, Thomas ED, Nathan DG, Gale RP, Kopecky KJ, Rappeport JM, Santos G, Gordon-Smith EC, Storb R (1979) A prospective study of androgens and bone marrow transplantation for aplastic anemia. Blood 53: 504 – 514
Bacigalupo A, Hows J, Gluckman E, Nissen C, Marsh J, van Lint MR, Congiu M, De Planque MM, Ernst P, Mc Cann S, Raghavachar A, Frickhofen N, Würsch A, Marmont AM, Gordon-Smith EC (1988) Bone marrow transplantation versus immunosuppression for the treatment of severe aplastic anemia. Br J Haematol 70: 177 – 182
Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogt HG, Herrmann F, Freund M, Meuseres P, Salama A, Heimpel H (1991) Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. N Engl J Med 324: 1297 – 1304
Antin JH, Smith BR, Holmes W, Rosenthal DS (1988) Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome. Blood 72: 705 – 713
Nissen C, Tichelli A, Gratwohl A, Speck B, Milne A, Gordon-Smith EC, Schaedelin J (1988) Failure of recombinant human granulocyte-macrophage colony stimulating factor therapy in aplastic anemia patients with very severe neutropenia. Blood 72: 2045 – 2047
Vadhan-Raj S, Buescher S, Le Maistre A, Keating M, Walters R, Ventura C, Hittelman W, Broxmeyer HE, Gutterman JH (1988) Stimulation of hematopoiesis in patients with bone marrow failure and in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor. Blood 72: 134 – 141
Vadhan-Raj S, Buescher S, Broxmeyer HE, Le Maistre A, Lepe-Zumiga JL, Ventura G, Jeka S, Horwitz LJ, Trujillo JM, Gillis S, Hittelman WN, Gutterman JU (1988) Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor. N Engl J Med 319: 1628 – 1634
Champlin RE, Nimer SD, Ireland P, Oette DH, Golde DW (1989) Treatment of refractory aplastic anemia with recombinant human granulocyte-macrophage colony stimulating factor. Blood 73: 694 – 699
Hinterberger W, Hoffmann S, Bettelheim P, Geißler K, Maurer D, Muhen M (1989) The use of growth factors in severe aplastic anemia. Bone Marrow Transplant 4 (Suppl 4): 129 – 130
Guinan EC, Sieff CA, Oette DH, Nathan DG (1990) A phase I/II trial of recombinant granulocyte-macrophage colony-stimulating factor for children with aplastic anemia. Blood 76: 1077 – 1082
Schuster MW, Lin ET, Solberg LA, Stadtmauer E, Bennett JM, Israel RJ (1990) Granulocyte-macrophage colony-stimulating factor (GM-CSF) for aplastic anemia: preliminary results of a multicenter randomized controlled trial. Blood 76 (Suppl 1): 47a
Herrmann F, Lindemann A, Raghavachar A, Heimpel H, Mertelsmann R (1990) In vivo recruitment of GM-CSF responsive myelopoietic progenitor cells by interleukin-3 in aplastic anemia. Leukemia 4: 671 – 672
Takahashi M, Nikkuni K, Moriyama Y, Shibata A (1991) GM-CSF mediated impairment of liver to synthesize albumin, cholinesterase, and cholesterol. Am J Hematol 36: 213 – 214
Kaczmarski RS, Mufti GJ (1990) Hypoalbuminemia after prolonged treatment with recombinant granulocyte-macrophage colony-stimulating factor. Br Med J 301: 1312 – 1313
Emminger W, Emminger-Schmidmeier W, Peters C, Susani M, Hawliczek R, Höcker P, Gadner H (1990) Capillary leak syndrome during low dose granulocyte macrophage colony-stimulating factor (rhGM-CSF) treatment of a patient in a continuous febrile state. Blut 61: 219 – 221
Arming M, Kliche KO, Schneider W (1991) GM-CSF therapy and capillary-leak syndrome (letter). Ann Hematol 62: 83
Kojima S, Fukuda M, Miyajima Y, Matsuyama T, Horibe K (1991) Treatment of aplastic anemia in children with recombinant human granulocyte colony-stimulating factor. Blood 77: 937 – 941
Potter MN, Mott MG, Oakhill A (1990) The successful treatment of a case of very severe aplastic anemia with granulocyte-macrophage colony-stimulating factor and antilymphocyte globulins. Br J Haematol 75: 618 – 619
Kojima S, Fukuda M, Miyajima Y, Matsuyama T (1990) Cyclosporine and recombinant granulocyte colony-stimulating factor in severe aplastic anemia. N Engl J Med 323: 920 – 921
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag, Berlin Heidelberg
About this paper
Cite this paper
Raghavachar, A. et al. (1992). Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Aplastic Anemia: A Phase I/II Trial with Emphasis on Very Severe Neutropenia and Active Infection. In: Freund, M., Link, H., Schmidt, R.E., Welte, K. (eds) Cytokines in Hemopoiesis, Oncology, and AIDS II. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-48715-6_69
Download citation
DOI: https://doi.org/10.1007/978-3-642-48715-6_69
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-55242-0
Online ISBN: 978-3-642-48715-6
eBook Packages: Springer Book Archive